[68Ga]Ga‐PSMA‐11 PET/CT for baseline staging of high‐risk prostate cancer: A real‐world study
Abstract Objective To use real‐world data to determine the clinical risk factors that are predictive of metastatic disease in high‐risk prostate cancer (PCa) patients undergoing staging [68Ga]Ga‐Prostate‐Specific Membrane Antigen (PSMA)‐11 positron emission tomography combined with computed tomograp...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2026-06-01
|
| Edice: | BJUI Compass |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/bco2.70209 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
